Eone Diagnomics Genome Center (245620)

KOSDAQ · 741 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

167.1B

Rev (2025)

7.9B

Op Inc (2025)

-1.6B

Net Inc (2025)

28.2B

52W

0K~0K

Eone Diagnomics Genome Center provides professional services. Professional Services

Legal name: Eone Diagnomics Genome Center Co., Ltd.

In fiscal year 2025, Eone Diagnomics Genome Center (245620) reported revenue of 7.9 billion KRW, down 74.5% from 30.9 billion KRW a year earlier.

Operating profit was -1.6 billion KRW and net income was 28.2 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 167.1 billion KRW.

These figures can be verified in the DART filing (receipt no. 20260407003694).

Year	Rev	Op Inc	Net Inc
2025	7.9B	-1.6B	28.2B
2024	30.9B	-12.6B	-95.2B
2023	88.5B	-9.4B	-33.0B

4 applicable out of 8 items

회생절차종결신청

기타시장안내 (투자주의 환기종목 지정 사유 일부 해제 관련 시장조치)

Semi-Annual Report (2026.06)

Checks

4 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 3 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.05% potential dilution.

Capital Increase: 2 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 4 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-26	회생절차종결신청
2026-08-14	기타시장안내 (투자주의 환기종목 지정 사유 일부 해제 관련 시장조치)
2026-08-14	Semi-Annual Report (2026.06)